9-methoxyphenazine-1-carboxylic acid | 23531-25-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 9-methoxyphenazine-1-carboxylic acid
• 英文别名: 9-methoxy-phenazine-1-carboxylic acid；9-Methoxyphenazin-1-carbonsaeure
• CAS: 23531-25-1
• 化学式: C₁₄H₁₀N₂O₃
• 分子量: 254.245
• InChiKey: DBKFFLIOIULEFA-UHFFFAOYSA-N

物化性质

• 熔点：
  262.5-263.0 °C(Solv: ethanol (64-17-5))
• 沸点：
  521.6±20.0 °C(Predicted)
• 密度：
  1.407±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  72.3
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  9-methoxyphenazine-1-carboxylic acid 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 反应 4.5h， 生成 9-methoxy-N-[3-[3-[(9-methoxyphenazine-1-carbonyl)amino]propyl-methylamino]propyl]phenazine-1-carboxamide
  参考文献：
  名称：

  Bis(phenazine-1-carboxamides):  Structure−Activity Relationships for a New Class of Dual Topoisomerase I/II-Directed Anticancer Drugs

  摘要：

  Ring-substituted bis(phenazine-1-carboxamides), linked by a -(CH2)(3)NMe(CH2)(3)- chain, were prepared from the corresponding substituted phenazine-1-carboxylic acids by reaction of the intermediate imidazolides with bis(3-aminopropyl)methylamine. The compounds were evaluated for growth inhibitory activity in a panel of tumor cell lines, including P388 leukemia, Lewis lung carcinoma, and wild-type (JL(C)) and mutant (JL(A) and JL(D)) forms of human Jurkat leukemia; The latter mutant lines are resistant to topoisomerase (topo) II targeted agents because of lower levels of the enzyme. Analogues with small, lipophilic substituents (e.g,, Me, Cl) at the 9-position were the most potent inhibitors, superior to the corresponding dimeric bis(acridine-4-carboxamides) (bis-DACA analogues). Several of the compounds were preferentially (up to 2-fold) more cytotoxic toward the mutant Jurkat lines than the wild-type. To test whether this selectivity was related to topoisomerase action, the most potent of the compounds (9-methyl) was evaluated in a cell-free system. It poisoned topo I at drug concentrations of 0.25 and 0.5 mu M and inhibited the catalytic activity of both topo I and topo II at concentrations of 1 and 5 mu M, respectively. Results from the NCI human tumor cell line panel showed the compounds had preferential activity toward colon tumor lines ton average 9.5-fold more active in the HT29 line than in the cell line, panel as a whole). Several analogues produced significant growth delays in the relatively refractory subcutaneous colon 38 tumor model in vivo. In particular, the 9-methyl compound was substantially more potent in this tumor model than the clinical dual topo I/II poison DACA (total dose 90 versus 400 mg/kg) with comparable activity. The bis(phenazine-1-carboxamides) are a new and interesting class of dual topo I/II-directed anticancer drugs.

  DOI：

  10.1021/jm990423f
• 作为产物：
  描述：

  2,6-二氟苯胺 在 N-乙基吗啉 、 sodium tetrahydroborate 、 sodium methylate 、 铜 、 copper(l) chloride 作用下， 以 various solvent(s) 为溶剂， 反应 26.0h， 生成 9-methoxyphenazine-1-carboxylic acid
  参考文献：
  名称：

  潜在的抗肿瘤药。51.取代的吩嗪-1-羧酰胺的合成和抗肿瘤活性。

  摘要：

  在对缺乏电子的DNA插入配体作为抗肿瘤药物的进一步研究中，合成并评估了一系列取代的N- [2-（二甲基氨基）乙基]吩嗪-1-羧酰胺。N-苯基-3-硝基邻氨基苯甲酸的氟定向闭环提供了几种必需的吩嗪-1-羧酸的新的，明确的合成，并制备了相应的羧酰胺，并针对体外L1210白血病和P388白血病进行了评估。刘易斯体内肺癌。吩嗪环上的取代被广泛耐受，并且所得化合物的细胞毒性与取代基的吸电子能力正相关。取代基的位置效应甚至更加明显，其中9-取代的化合物最为活跃。一阶导数

  DOI：

  10.1021/jm00388a017

文献信息

• N-(Tetrazol-5-yl)phenazine-1-carboxamides
  申请人：Minnesota Mining and Manufacturing Company

  公开号：US04377579A1

  公开（公告）日：1983-03-22

  Amides obtained by reaction of aminotetrazole and certain optionally substituted phenazinecarboxylic acids are potent anti-allergic agents.

  通过氨基四唑和某些可选取代的苯并咪唑羧酸反应得到的酰胺是有效的抗过敏剂。
• [EN] BIS(ACRIDINECARBOXAMIDE) AND BIS(PHENAZINECARBOXAMIDE) AS ANTITUMOUR AGENTS<br/>[FR] (BIS)ACRIDINECARBOXAMIDE ET (BIS)PHENAZINECARBOXAMIDE UTILISES EN TANT QU'AGENTS ANTITUMORAUX
  申请人：XENOVA LIMITED

  公开号：WO1998017650A1

  公开（公告）日：1998-04-30

  (EN) A compound which is a bis(acridinecarboxamide) or bis(phenazinecarboxamide) derivative of formula (I), wherein each X, which may be the same or different in a given molecule, is -CH= or -N= each of R1 to R4 which may be the same or different, H, C1-C4 alkyl, OH, SH, NH2, C1-C4 alkoxy, aryloxy, NHR, N(R)2, SR, SO2R wherein R is C1-C4 alkyl, CF3, NO2 or halogen, or R1 and R2 together form a methylenedioxy group; each of R5 and R6, which may be the same or different, is H or C1-C4 alkyl; Z is (CH2)n, (CH2)nO(CH2)n, (CH2)nN(R7) (CH2)n, (CH2)nN(R7) (CH2)mN(R7) (CH2)n or (CH2)nN(CH2CH2)2N(CH2)n wherein R7 is H or C1-C4 alkyl and n and m, which may be the same or different, are each an integer of 1 to 4; or a pharmaceutically acceptable acid addition salt or N-oxide thereof; has activity as an antitumour and antibacterial agent.(FR) L'invention concerne un composé qui est dérivé de (bis)acridinecarboxamide et de (bis)phénazinecarboxamide de formule (I), dans laquelle chaque X, qui peut être identique ou différent dans une molécule donnée, représente -CH= ou -N=, chacun des R1 à R4, qui peuvent être identiques ou différents, représentant H, un alkyle en C1-C4, OH, SH, NH2, un alkoxy en C1-C4, un aryloxy, NHR; N(R)2, SR, SO2R, R représentant un alkyle en C1-C4, CF3, NO2 ou halogène, ou R1 et R2 formant ensemble un groupe méthylènedioxy; chacun des R5 et R6, qui peuvent être identiques ou différents, représentant H ou un alkyle en C1-C4; Z représente (CH2)n, (CH2)nO(CH2)n, (CH2)nN(R7) (CH2)nN(R7) (CH2)mN(R7) (CH2)n ou (CH2)nN(CH2CH2)2N(CH2)n, R7 représentant H ou un alkyle en C1-C4, et n et m, qui peuvent être identiques ou différents, représentant chacun un nombre entier allant de 1 à 4; ou un sel d'addition d'acide pharmaceutiquement acceptable, ou un N-oxyde dudit sel; présente une activité en tant qu'agent antitumoral et antibactérien.

  一种化合物，其为公式(I)的双(吖啶甲酰胺)或双(菲嗪甲酰胺)衍生物，其中每个X在给定分子中可以相同或不同，为-CH=或-N=，每个R1到R4可以相同或不同，为H、C1-C4烷基、OH、SH、NH2、C1-C4烷氧基、芳氧基、NHR、N(R)2、SR、SO2R，其中R为C1-C4烷基、CF3、NO2或卤素，或者R1和R2组成一个亚甲二氧基基团；每个R5和R6可以相同或不同，为H或C1-C4烷基；Z为(CH2)n、(CH2)nO(CH2)n、(CH2)nN(R7)(CH2)n、(CH2)nN(R7)(CH2)mN(R7)(CH2)n或(CH2)nN(CH2CH2)2N(CH2)n，其中R7为H或C1-C4烷基，n和m可以相同或不同，均为1到4的整数；或其药学上可接受的酸加盐或N-氧化物；具有抗肿瘤和抗菌活性。
• N-(tetraxol-5-yl)phenazine-1-carboxamides
  申请人：RIKER LABORATORIES, INCORPORATED

  公开号：EP0081338A1

  公开（公告）日：1983-06-15

  Compounds of the formula: wherein R is a hydrogen atom or a C1-C4 alkyl group, X is a hydrogen atom, halogen atom, or a methoxy or methyl group, and Y is a hydrogen atom, halogen atom, or a methoxy or ethoxy group. These compounds are potent anti-allergic agents.

  式中 R 是氢原子或 C1-C4 烷基，X 是氢原子、卤素原子或甲氧基或甲基，Y 是氢原子、卤素原子或甲氧基或乙氧基。 这些化合物是强效抗过敏剂。
• Phenazinecarboxamide compounds
  申请人：DEVELOPMENT FINANCE CORPORATION OF NEW ZEALAND

  公开号：EP0172744A2

  公开（公告）日：1986-02-26

  The novel class of phenazine derivatives of the present invention represented by the general formula where R, represents H or up to three substituents, at positions selected from 2 to 4 and 6 to 9, wherein any two or all of the substituents may be the same or different and the substituents are selected from lower alkyl radicals; lower alkyl radicals substituted by one or more of the same or different substituents selected from hydroxy, amino and ether functions; OH, SH; OCH2Ph; OPh; N02; halogen; CF3; amino; NHSO2R2, NHCOR2, NHCOOR2, OR2 and SR2 (where R2 represents a lower alkyl radical which is unsubstituted or substituted by one or more of the same or different substituents selected from hydroxy, amino and ether functions); and CONH(CH2)n'Y (where n' and Y' are as defined below), there being a maximum of one CONH(CH2)n'Y' group; or any two of R, at adjacent positions represent -CH=CH-CH=CH- as part of an extra benzene ring or -O-CH2-O- (methylenedioxy) and the third of R, has any one of the meanings given above with the exception of an OH at position 2; Y and Y', which may be the same or different, each represents C(NH)NH2, NHC(NH)NH2 or NR3R4, where each of R3 and R4, which may be the same or different, represents H or a lower alkyl radical unsubstituted or substituted by one or more of the same or different substituents selected from hydroxy, amino and ether functions, or R3 and R4, together with the nitrogen atom to which they are attached, form a heterocyclic ring; and n and n', which may be the same or different, each represents an integer from 2 to 6; and the acid addition salts, 5- and 10- mono-N-oxides and 5,10-di-N-oxides thereof, possess antibacterial and antitumour properties.

  本发明的一类新型吩嗪衍生物由通式表示 其中 R 代表 H 或最多三个取代基，位于选自 2 至 4 和 6 至 9 的位置，其中任意两个或所有取代基可以相同或不同，取代基选自 低级烷基 被一个或多个相同或不同的取代基取代的低级烷基，取代基可选自羟基、氨基和醚官能团； 羟基 SH； OCH2Ph； OPh； N02; 卤素；CF3；氨基； NHSO2R2、NHCOR2、NHCOOR2、OR2 和 SR2（其中 R2 代表未被取代或被一个或多个选自羟基、氨基和醚官能团的相同或不同取代基取代的低级烷基）；以及 CONH(CH2)n'Y（其中 n'和 Y'定义如下），最多一个 CONH(CH2)n'Y'基团；或相邻位置的任意两个 R 代表-CH=CH-CH=CH-（作为额外苯环的一部分）或-O-CH2-O-（亚甲基二氧基），第三个 R 具有上述任何一种含义，但位置 2 上的 OH 除外； Y 和 Y'（可以相同或不同）各自代表 C(NH)NH2、NHC(NH)NH2 或 NR3R4，其中 R3 和 R4（可以相同或不同）各自代表 H 或未取代的低级烷基或被选自羟基、氨基和醚官能团的一个或多个相同或不同取代基取代的低级烷基，或 R3 和 R4 与它们所连接的氮原子一起形成杂环；以及 n 和 n'（可以相同或不同）分别代表 2 至 6 的整数；酸加成盐、5-和 10-单-N-氧化物及其 5,10-二-N-氧化物具有抗菌和抗肿瘤特性。
• Rewcastle, Gordon W; Denny, William A, Synthetic Communications, 1987, vol. 17, # 10, p. 1171 - 1180
  作者：Rewcastle, Gordon W、Denny, William A

  DOI：——

  日期：——